212 related articles for article (PubMed ID: 36552744)
1. Systematic Analysis of a Pyroptosis-Related Signature to Predict the Prognosis and Immune Microenvironment of Lower-Grade Glioma.
He Y; Cai Y; Liu J; Ding H; Li X; Tian S; Li Z
Cells; 2022 Dec; 11(24):. PubMed ID: 36552744
[TBL] [Abstract][Full Text] [Related]
2. Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma.
Yu H; Gong M; Qi J; Zhao C; Niu W; Sun S; Li S; Hong B; Qian J; Wang H; Chen X; Fang Z
BMC Cancer; 2022 Aug; 22(1):885. PubMed ID: 35964070
[TBL] [Abstract][Full Text] [Related]
3. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
[No Abstract] [Full Text] [Related]
4. Pyroptosis-Related Genes as Markers for Identifying Prognosis and Microenvironment in Low-Grade Glioma.
Han J; Jing Y; Sun P
J Healthc Eng; 2023; 2023():6603151. PubMed ID: 36820395
[TBL] [Abstract][Full Text] [Related]
5. Prognostic characterization of the pyroptosis-related subtypes and tumor microenvironment infiltration in glioma.
He J; Zhou W; Zhang M
Cancer Biomark; 2023; 37(3):161-177. PubMed ID: 37248887
[TBL] [Abstract][Full Text] [Related]
6. Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma.
Wang J; Ren J; Liu J; Zhang L; Yuan Q; Dong B
Bosn J Basic Med Sci; 2022 Sep; 22(5):728-750. PubMed ID: 35276059
[TBL] [Abstract][Full Text] [Related]
7. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.
He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C
Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the Role of Pyroptosis in Lower-Grade Glioma: Development of a Novel Scoring System to Enhance Personalized Therapeutic Approaches.
Chen X; Xu Y; Wang M; Ren C
J Mol Neurosci; 2023 Aug; 73(7-8):649-663. PubMed ID: 37566191
[TBL] [Abstract][Full Text] [Related]
9. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
Front Immunol; 2022; 13():961933. PubMed ID: 35990696
[TBL] [Abstract][Full Text] [Related]
10. A pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in glioma.
Chen J; Chen S; Li B; Zhou S; Lin H
Cancer Med; 2023 Feb; 12(4):5071-5087. PubMed ID: 36161280
[TBL] [Abstract][Full Text] [Related]
11. Pyroptosis-related prognosis model, immunocyte infiltration characterization, and competing endogenous RNA network of glioblastoma.
Ding MR; Qu YJ; Peng X; Chen JF; Zhang MX; Zhang T; Hu B; An HM
BMC Cancer; 2022 Jun; 22(1):611. PubMed ID: 35658846
[TBL] [Abstract][Full Text] [Related]
12. A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma.
Huang Q; Li J; Mo L; Zhao Y
World Neurosurg; 2022 Mar; 159():e285-e302. PubMed ID: 34929369
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of a Gene Signature for Lower-Grade Gliomas Based on Pyroptosis-Related Genes to Predict Survival and Response to Immune Checkpoint Inhibitors.
Lai G; Li K; Deng J; Liu H; Xie B; Zhong X
J Healthc Eng; 2022; 2022():8704127. PubMed ID: 35535221
[TBL] [Abstract][Full Text] [Related]
14. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
Front Immunol; 2022; 13():899710. PubMed ID: 35677036
[TBL] [Abstract][Full Text] [Related]
15. Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas.
Li Y; Feng Y; Luo F; Peng G; Li Y
Front Immunol; 2022; 13():1089792. PubMed ID: 36726969
[TBL] [Abstract][Full Text] [Related]
16. Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma.
Liu H; Tao T
Front Oncol; 2022; 12():1015850. PubMed ID: 36605437
[TBL] [Abstract][Full Text] [Related]
17. Identification of a pyroptosis-related prognosis gene signature and its relationship with an immune microenvironment in gliomas.
Xiao S; Yan Z; Zeng F; Lu Y; Qiu J; Zhu X
Medicine (Baltimore); 2022 Jul; 101(28):e29391. PubMed ID: 35839032
[TBL] [Abstract][Full Text] [Related]
18. Machine Learning-Based Integration Develops a Pyroptosis-Related lncRNA Model to Enhance the Predicted Value of Low-Grade Glioma Patients.
Wu J; Lu L; Wang C; Jiang F
J Oncol; 2022; 2022():8164756. PubMed ID: 35646114
[TBL] [Abstract][Full Text] [Related]
19. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a pyroptosis-related genes signature for risk stratification in gliomas.
Sun P; Wang X; Zhong J; Yu D; Xuan H; Xu T; Song D; Yang C; Wang P; Liu Y; Meng X; Cai J
Front Genet; 2023; 14():1087563. PubMed ID: 36861130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
